COMMUNIQUÉS West-GlobeNewswire

Elite Pharmaceuticals Receives FDA Approval for Hydrocodone and Acetaminophen Combo
20/11/2018
NORTHVALE, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
20/11/2018
WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,130,810 titled “Transcutaneous electrical nerve [...]
EDAP TMS SA : EDAP to Present a Corporate Update at the 30th Annual Piper Jaffray Conference
20/11/2018
LYON, France, November 20, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper Jaffray Conference, taking place November [...]
Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program in Olanzapine-Induced Weight Gain
20/11/2018
Zug, Switzerland, November 20, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health [...]
Shire plc: Phase I conditional clearance by the European Commission
20/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION FOR [...]
Data from Phase III MAIA Study of Daratumumab Accepted for Presentation at Annual Meeting of American Society of Hematology
20/11/2018
Media Release Data from Phase III MAIA study in front line multiple myeloma accepted as Late-breaking Abstract for oral presentation at ASH Annual Meeting Copenhagen, Denmark; November 20, 2018 – Genmab A/S (Nasdaq [...]
Aptevo Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference
20/11/2018
SEATTLE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that management will be [...]
Alzamend Neuro™ Appoints New CEO, Bio-Pharma Executive Stephan Jackman
20/11/2018
Salt Lake City, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that it has appointed bio-pharma executive, Mr. Stephan Jackman, as its new Chief Executive Officer in [...]
Pure Global Poised to Advance Its Innovative Products to Distribution Channels -- CFN Media
20/11/2018
SEATTLE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
20/11/2018
Collaboration to evaluate ZEN-3694 in combination with Talazoparib in TNBC patients; Phase 1b/2 trial expected to initiate 1Q 2019 CALGARY, Alberta, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or [...]
ChemoCentryx to Present at the 30th Annual Piper Jaffray Healthcare Conference
20/11/2018
MOUNTAIN VIEW, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the 30th Annual Piper [...]
PSIQ Elects Eddie Nurieli, Esquire to Its Board of Directors and Member of Audit Committee
20/11/2018
SUNRISE, Fla., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces the appointment of Eddie Nurieli, Esquire (“Nurieli”), a seasoned attorney specializing in real estate, business and [...]
Novartis rises to second place in 2018 Access to Medicine Index
20/11/2018
Company leads the industry in access-to-medicine management thanks to long- term commitment, as well as ongoing innovation in access to healthcare Novartis moves up one position from number 3 in 2016 Report highlights [...]
Novan to Present at Piper Jaffray 30th Annual Healthcare Conference
20/11/2018
MORRISVILLE, N.C., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that Paula Brown Stafford, Chief Development Officer, and Nathan Stasko, President and Chief [...]
Nemaura Signs License and Distribution Agreement for SugarBEAT® Commercial Launch in Qatar
20/11/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes [...]
IntelGenx Announces FDA’s Acceptance of Resubmission of New Drug Application for RIZAPORT®
20/11/2018
- PDUFA Goal Date of April 1, 2019 - SAINT LAURENT, Quebec, Nov. 20, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today announced that its 505(b)(2) New Drug [...]
BioSig Technologies Reinvests in Lafayette College’s InternShift Progam
20/11/2018
Santa Monica, CA, Nov. 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Krystal Biotech to Present at Evercore ISI HealthCONx
20/11/2018
PITTSBURGH, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin [...]
Immune Design to Present at Piper Jaffray 30th Annual Healthcare Conference
20/11/2018
SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced that management will [...]

Pages